United States · FDA National Drug Code directory
Alendronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-1676_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1
- Product NDC
- 0115-1676
- Form
- TABLET
- Composition / generic term
- Alendronate Sodium
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080206
- Source listing expiry
- 20261231
Source-listed ingredients
- ALENDRONATE SODIUM — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (0115-1676-01) · 0115-1676-01
- 30 TABLET in 1 BOTTLE (0115-1676-08) · 0115-1676-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →